Aditxt, Inc. Files 8-K: Regulation FD Disclosure & Exhibits
Ticker: ADTX · Form: 8-K · Filed: Aug 11, 2025 · CIK: 1726711
Sentiment: neutral
Topics: disclosure, exhibits, regulation-fd
TL;DR
Aditxt filed an 8-K on Aug 11 for an Aug 6 event - Reg FD disclosure & exhibits.
AI Summary
Aditxt, Inc. filed an 8-K on August 11, 2025, reporting an event on August 6, 2025. The filing is a Regulation FD Disclosure and includes Financial Statements and Exhibits. The company, formerly known as Aditx Therapeutics, Inc., is incorporated in Delaware and its principal executive offices are located in Mountain View, CA.
Why It Matters
This 8-K filing provides important updates and disclosures from Aditxt, Inc. to the public, ensuring transparency regarding company events and financial information.
Risk Assessment
Risk Level: low — This filing is a standard 8-K for disclosures and exhibits, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- Aditxt, Inc. (company) — Registrant
- August 6, 2025 (date) — Earliest event reported
- August 11, 2025 (date) — Filing date
- Regulation FD Disclosure (disclosure) — Item Information
- Financial Statements and Exhibits (document) — Item Information
- Aditx Therapeutics, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Mountain View, CA (location) — Principal executive offices
FAQ
What specific event occurred on August 6, 2025, that necessitated this 8-K filing?
The filing indicates an event occurred on August 6, 2025, and it is categorized under 'Regulation FD Disclosure' and 'Financial Statements and Exhibits', but the specific details of the event are not provided in this excerpt.
What is the primary purpose of this 8-K filing for Aditxt, Inc.?
The primary purpose is to report an event that occurred on August 6, 2025, under 'Regulation FD Disclosure' and to file 'Financial Statements and Exhibits'.
When was Aditxt, Inc. previously known by another name?
Aditxt, Inc. was formerly known as Aditx Therapeutics, Inc., with a name change date of November 13, 2020.
Where are Aditxt, Inc.'s principal executive offices located?
Aditxt, Inc.'s principal executive offices are located at 2569 Wyandotte Street, Suite 101, Mountain View, CA 94043.
What is the SIC code for Aditxt, Inc.?
The Standard Industrial Classification (SIC) code for Aditxt, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 1,164 words · 5 min read · ~4 pages · Grade level 14.1 · Accepted 2025-08-11 16:30:40
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 ADTX The Nasdaq Stock Market LLC
Filing Documents
- ea0252550-8k_aditxt.htm (8-K) — 32KB
- ea025255001ex99-1_aditxt.htm (EX-99.1) — 92KB
- 0001213900-25-074330.txt ( ) — 316KB
- adtx-20250806.xsd (EX-101.SCH) — 3KB
- adtx-20250806_lab.xml (EX-101.LAB) — 33KB
- adtx-20250806_pre.xml (EX-101.PRE) — 22KB
- ea0252550-8k_aditxt_htm.xml (XML) — 4KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits. Exhibit No. Exhibit 99.1 Transcript of Wall Street Reporter's Next Super Stock livestream event – August 6, 2025 104 Cover Page Interactive Data File (embedded within the XBRL document) -1- SIGNATURE Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 11, 2025 Aditxt, Inc. By: /s/ Amro Albanna Name: Amro Albanna Title: Chief Executive Officer -2-